Larvol Delta - Malignant-Pleural-Disease-Treated-With-Autologous-T-Cells-Genetically-Engineered-to-Target-the-CancerCell-Surface-Antigen-Mesothelin

iCasp9M28z T cell infusion - Memorial Sloan-Kettering Cancer Center, Bellicum

cyclophosphamide - Generic mfg.

Keytruda (pembrolizumab) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT02414269

Jul 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next